Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Phillip W. Kantoff
Based on 201 articles published since 2010
(Why 201 articles?)
||||
Expertise Level
The expertise of Phillip W. Kantoff ranks in the
  • Top 0.014%
  • ... of 150,464 published authors worldwide on Prostatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 201 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kantoff, P W   ·   Kantoff, P   ·   Kantoff, Philip   ·   Kantoff, Philip W   ·   Kantoff, Phillip W
Work Locations
Details
Most likely:    Memorial Sloan-Kettering Cancer Center   Contact    
2020
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 32385899
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 32317181
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
  • Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Jefferson College of Population Health, Philadelphia, PA, USA. Electronic address: · Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA. · Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Department of Pharmacy Practice, Jefferson College of Pharmacy, Philadelphia, PA, USA. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Jefferson Senior Adult Oncology Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Center for Prostate Disease Research (CPDR), Rockville, MD, USA. · Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Department of Urology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Pubmed 31420248
  • Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Surgery, University of California, San Francisco, San Francisco, CA. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Pathology, Johns Hopkins Bayview Medical Center, Baltimore, MD. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA. · Pubmed 31318977
2019
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA; email: · Pubmed 30691365
  • Department of Urology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Section of Urology, Durham VA Medical Center, Durham, NC, USA. · Library for the Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, GU section, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Electronic address: · Pubmed 29673712
  • 1 National Institutes of Health, Bethesda, MD. · 2 Aarhus Universitetshospital, Åarhus, Denmark. · 3 Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · 4 St John of God Subiaco Hospital, Subiaco, Western Australia, Australia. · 5 University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · 6 Royal Marsden Hospital, Sutton, United Kingdom. · 7 Monash Medical Centre, Bentleigh, Victoria, Australia. · 8 Herlev Hospital, Herlev, Denmark. · 9 University of Colorado Cancer Center, Aurora, CO. · 10 Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · 11 Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. · 12 Carolina Urologic Research Center, Myrtle Beach, SC. · 13 Bavarian Nordic, Morrisville, NC. · 14 Radboudumc, Nijmegen, the Netherlands. · 15 Centre Hospitalier Départemental, La Roche sur Yon, France. · 16 Aalborg Universitethospital, Aalborg, Denmark. · 17 North-Western State Medical University, Saint Petersburg, Russia. · 18 Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30817251
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, QC, Canada. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Pathology Service, Addarii Institute of Oncology, S-Orsola-Malpighi Hospital, Bologna, IT, Italy. · Metabolon, Morrisville, NC, USA. · Decipher Biosciences, Vancouver, BC, Canada. · James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology, Mayo Clinic Rochester, Rochester, MN, USA. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Surgery Section, Durham Veteran Affairs Medical Center, Durham, NC, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Department of Pathology and Laboratory Medicine, Weil Cornell Medicine, New York Presbyterian-Weill Cornell Campus, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 31554818
  • Division of Medical Oncology, Departments of Medicine and Urology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Division of Urology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Section of Hematology and Medical Oncology, Department of Medicine, Tulane Cancer Center and Tulane University School of Medicine, New Orleans, Louisiana. · Division of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Department of Surgery, Center for Prostate Disease Research at the Uniformed Services of Health Sciences, Bethesda, Maryland. · Associated Medical Professionals, Syracuse, New York. · Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, South Carolina. · New York Cancer and Blood Specialists, New York, New York. · Urology Associates PC, Nashville, Tennessee. · Chesapeake Urology, Towson, Maryland. · Department of Medical Oncology, GU Research Network, Omaha, Nebraska. · Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Advanced Urology, Atlanta, Georgia. · Prostate Cancer Research Institute, Marina del Rey, California. · Department of Biometrics, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Medical Affairs, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Pubmed 31483485
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 31225930
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115; · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; · Howard Hughes Medical Institute, Chevy Chase, MD 20815. · Pubmed 31085648
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Pathology, Weill Medical College of Cornell University, New York, NY 10021. · Department for Biomedical Research, University of Bern, 3008 Bern, Switzerland. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123 Trento, Italy. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109. · Department of Pathology, University of Michigan, Ann Arbor, MI 48109. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215. · Broad Institute, Cambridge, MA 02142. · Institute of Cancer Research, London SW7 3RP, United Kingdom. · The Royal Marsden National Health Service Foundation Trust, London SM2 5NG, United Kingdom. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Prostate Cancer Clinical Trials Consortium, New York, NY 10065. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021. · Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201. · Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109; · Department of Pathology, Weill Medical College of Cornell University, New York, NY 10021; · Department of Pathology, University of Michigan, Ann Arbor, MI 48109; · Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Pubmed 31061129
  • HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA. Electronic address: · Department of Orthopaedic Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA; Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: · Department of Urology, Queen's University, Kingston, ON, Canada. Electronic address: · HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: · Pubmed 30850323
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Computer Science and Statistics, University of Rhode Island, South Kingstown, RI. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Mount Sinai School of Medicine, New York, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30664895
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Sapienza Università di Roma, Rome, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 30643173
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 30589920
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 30589919
  • HealthCore-NERI, Watertown, MA, USA. · Kingston General Hospital, Queen's University, Kingston, ON, Canada. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA. · Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA, USA. · Departments of Orthopaedic Surgery and Urology, Boston Children's Hospital, Boston, MA, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30216624
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Harvard T. H. Chan Harvard School of Public Health, Boston, Massachusetts. · Pubmed 30141208
2018
  • Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center · Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine · S. Bruce Malkowicz, University of Pennsylvania · Elias Obeid and Robert Uzzo, Fox Chase Cancer Center · Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia · Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA · Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center · Mitchell C. Benson, Columbia University, New York, NY · Gerald L. Andriole, Washington University School of Medicine, St Louis, MO · Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands · Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco · Christopher J. Kane, University of California San Diego, San Diego · Howard Sandler, Cedars-Sinai Medical Center, Los Angeles · Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA · Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore · Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD · William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine · Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL · Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT · David E. Crawford, University of Colorado, Aurora · Lawrence I. Karsh, The Urology Center of Colorado, Denver · Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO · Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA · Freddie C. Hamdy, University of Oxford, Oxford, England · R. Jeffrey Karnes, Mayo Clinic, Rochester, MN · Eric A. Klein, Cleveland Clinic, Cleveland · Robert Pilarski, The Ohio State University, Columbus, OH · Daniel W. Lin, University of Washington, Seattle, WA · Martin M. Miner, Brown University, Providence, RI · Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor · Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI · Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC · David F. Penson, Vanderbilt University Medical Center, Nashville, TN · Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT · Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston · Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX · Oliver Sartor, Tulane University Medical School, New Orleans, LA · Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC · and Richard Wender, American Cancer Society, Atlanta, GA. · Pubmed 29236593
  • Department of Urology, Osaka Medical College, Takatsuki, Osaka, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 29266472
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. Electronic address: · University of Colorado Cancer Center, Aurora, Colorado. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Roswell Park Cancer Institute, Buffalo, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Janssen Scientific Affairs, LLC, Horsham, Pennsylvania. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29630978
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Oncology Division, Immunomic Therapeutics, Inc., Rockville, MD, USA. · Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. · Hematology Division, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medicine, Harvard Medical School, Boston, MA, USA. · Nanotechnology Engineering Program, University of Waterloo, Waterloo, Ontario, Canada. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. · Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · King Abdulaziz University, Jeddah, Saudi Arabia. · Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 31015614
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Medicine and Department of Pathology, David Geffen School of Medicine at University of California , Los Angeles, California. · Program on Aging, Hebrew Senior Life, Roslindale, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College , New York, New York. · Department of Radiation Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Pubmed 30325657
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Trinity College Dublin, Dublin, Ireland. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California. · Department of Medicine, Clinical Epidemiology Unit, Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · National Cancer Institute, Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Bethesda, Maryland. · Pubmed 30108097
  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. · Department of Epidemiology, Boston University School of Public Health, Boston, MA, 02118, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. · Pubmed 29915914
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · McMaster University, Hamilton, Ontario, Canada. · University of Colorado Denver, Denver, Colorado. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 29882250
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Urology and. · Translational Research Program, Osaka Medical College, Osaka, Japan. · Division of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Molecular Cytogenetics Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of General and Gastroenterological Surgery, Osaka Medical College, Osaka, Japan. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Pubmed 29863497
  • Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, Boston, Massachusetts. · Sapienza University of Rome, Rome, Italy. · Hospital Santa Izabel, Salvador, Bahia, Brazil. · University of Colorado Cancer Center, Aurora, Colorado. · Institut Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29707790
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA. · Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA. · Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. · Centre for Integrated Biology, University of Trento, Trento, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Pubmed 29610475
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29338073
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Sapienza Università di Roma, Rome, Italy. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, AB, Canada. · St Vincent's Hospital, Sydney, Australia. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29331381
  • Harvard Radiation Oncology Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Computer Science and Statistics, University of Rhode Island, Kingston, Rhode Island. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, University of California at San Francisco, San Francisco, California. · Pubmed 29266181
  • Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA, USA. · Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Surgery, Division of Urology, Dana Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Department of Urology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 29263420
  • Department of Medicine, Duke Cancer Institute, Durham, New York, USA. · Department of Oncology, Johns Hopkins University, Baltimore, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, Weill Cornell Medical College, New York, USA. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA. · Carolina Urologic Research Center, Myrtle Beach, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Weill Cornell Medical College, New York, USA. · Department of Medicine, MD Anderson Cancer Center, Houston, USA. · School of Medicine, University of Virginia, Charlottesville, USA. · Division of Hematology/Oncology, Wayne State University, Detroit, USA. · Division of Hematology/Oncology, University of Wisconsin, Madison, USA. · Department of Medicine, Rutgers Cancer Institute of New Jersey, Newark, USA. · Massachusetts General Hospital, Cancer Center, Boston, USA. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Division of Human Biology, University of Washington, Seattle, USA. · Fred Hutchinson Cancer Center, Seattle, USA. · Department of Urology, The Christie Clinic, National Health Service, Manchester, UK. · Department of Urology, UC Davis, Sacramento, USA. · Department of Oncology, University Hospital Aschen, Cologne, Germany. · Department of Urology, University Hospital St. Etienne, Saint-Etienne, France. · Department of Urologic Sciences, Vancouver Prostate Centre, Vancouver, Canada. · Pubmed 29088323
  • Department of Radiation Oncology, University of Michigan, Ann Arbor. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Medicine, Memorial Sloan Kettering Cancer Center New York, New York. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 29049492
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Program on Aging, Hebrew SeniorLife, Roslindale, Massachusetts, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: · Pubmed 28941963
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2017
  • Lorelei A. Mucci, Harvard TH Chan School of Public Health, Boston, MA · and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28817369
  • Fred Hutchinson Cancer Research Center, Seattle, Washington. · Palo Alto Medical Foundation, Palo Alto, California. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · Lerner Research Institute, Glickman Urological and Kidney Institute, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington. · University of Washington, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28389510
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY · James L. Gulley, National Cancer Institute, Bethesda, MD · and Cesar Pico-Navarro, Bavarian Nordic, Redwood City, CA. · Pubmed 27646950
  • Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Pubmed 28886115
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA · Marc Buyse, International Drug Development Institute · Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve · Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Susan Halabi, Duke University Medical Center, Durham, NC · Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY · Oliver Sartor, Tulane Medical School, New Orleans, LA · Howard Soule, Prostate Cancer Foundation, Santa Monica · Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA · Noel W. Clarke, The Christie NHS Foundation Trust, Manchester · Matthew R. Sydes, University College London, London, United Kingdom · James J. Dignam, University of Chicago, Chicago, IL · Karim Fizazi, Institut Gustave-Roussy, Villejuif, France · Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada · and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, Ohio State University, Columbus, Ohio. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Pubmed 28700821
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts. · Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Physics of Complex Systems Eotvos Lorand University, Budapest, Hungary. · Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. · Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Institute, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, New York. · Pubmed 28608931
  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Division of Hematology/Oncology, University of California, Moores Cancer Center, San Diego, CA, USA. · Analysis Group, Inc., Boston, MA, USA. · Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28220804
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28117382
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts2Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Baptist Hospital, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Institute, New York, New York. · Pubmed 28097317
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27824043
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston · Robert W. Ross, Bluebird Bio, Cambridge, MA · Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX · Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI · Michael A. Carducci, Johns Hopkins University · Arif Hussain, Greenebaum Cancer Center, Baltimore, MD · Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI · and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • University of Wisconsin Carbone Cancer Center, 7007 WIMR, 1111 Highland Avenue, Madison, WI 53705 USA. · Weill Medical College of Cornell University, Laboratory of Urological Oncology E-300, 525 East 68th Street, New York, NY 10021 USA. · Oregon Health and Science University Knight Cancer Institute, 3181 SW Sam Jackson Park Road, Portland, OR 97239 USA. · Johns Hopkins University, 1650 Orleans Street Room 410, Baltimore, MD 21287 USA. · University of California, San Francisco, 513 Parnassus Ave, Room HSF 301, Box 1270, San Francisco, CA 94143 USA. · Carolina Urologic Research Center, 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572 USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 USA. · National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892 USA. · Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1079, New York, NY 10029 USA. · University of Illinois, 840 S Wood Street, Suite 820, Chicago, IL 60612 USA. · Yale Cancer Center, PO Box 208032, New Haven, CT 06520 USA. · Alliance for Prostate Cancer Prevention, 17660 Tamiami Trail, Suite 106, Fort Myers, FL 33908 USA. · Tulane University School of Medicine, 1430 Tulane Ave, SL-42, New Orleans, LA 70112 USA. · Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903 USA. · Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328 USA. · Genitourinary Malignancies Branch, 10 Center Drive, 13N240, Bethesda, MD 20892 USA. · Pubmed 28031820
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute · Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA · Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT · Andrew Renshaw, Miami Baptist Hospital, Miami, FL · and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Department of Urology, Weill Cornell Medical Center, 1300 York Avenue, New York, NY, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, 600 Third Avenue, New York, NY, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Pubmed 27439668
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
2012
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 22802323
Probable:    NewYork-Presbyterian Hospitals      
2020
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
2019
  • Division of Medical Oncology, Departments of Medicine and Urology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Division of Urology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Section of Hematology and Medical Oncology, Department of Medicine, Tulane Cancer Center and Tulane University School of Medicine, New Orleans, Louisiana. · Division of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Department of Surgery, Center for Prostate Disease Research at the Uniformed Services of Health Sciences, Bethesda, Maryland. · Associated Medical Professionals, Syracuse, New York. · Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, South Carolina. · New York Cancer and Blood Specialists, New York, New York. · Urology Associates PC, Nashville, Tennessee. · Chesapeake Urology, Towson, Maryland. · Department of Medical Oncology, GU Research Network, Omaha, Nebraska. · Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Advanced Urology, Atlanta, Georgia. · Prostate Cancer Research Institute, Marina del Rey, California. · Department of Biometrics, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Medical Affairs, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Pubmed 31483485
  • HealthCore-NERI, Watertown, MA, USA. · Kingston General Hospital, Queen's University, Kingston, ON, Canada. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA. · Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA, USA. · Departments of Orthopaedic Surgery and Urology, Boston Children's Hospital, Boston, MA, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30216624
2018
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Medicine and Department of Pathology, David Geffen School of Medicine at University of California , Los Angeles, California. · Program on Aging, Hebrew Senior Life, Roslindale, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College , New York, New York. · Department of Radiation Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Pubmed 30325657
  • Department of Medicine, Duke Cancer Institute, Durham, New York, USA. · Department of Oncology, Johns Hopkins University, Baltimore, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, Weill Cornell Medical College, New York, USA. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA. · Carolina Urologic Research Center, Myrtle Beach, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Weill Cornell Medical College, New York, USA. · Department of Medicine, MD Anderson Cancer Center, Houston, USA. · School of Medicine, University of Virginia, Charlottesville, USA. · Division of Hematology/Oncology, Wayne State University, Detroit, USA. · Division of Hematology/Oncology, University of Wisconsin, Madison, USA. · Department of Medicine, Rutgers Cancer Institute of New Jersey, Newark, USA. · Massachusetts General Hospital, Cancer Center, Boston, USA. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Division of Human Biology, University of Washington, Seattle, USA. · Fred Hutchinson Cancer Center, Seattle, USA. · Department of Urology, The Christie Clinic, National Health Service, Manchester, UK. · Department of Urology, UC Davis, Sacramento, USA. · Department of Oncology, University Hospital Aschen, Cologne, Germany. · Department of Urology, University Hospital St. Etienne, Saint-Etienne, France. · Department of Urologic Sciences, Vancouver Prostate Centre, Vancouver, Canada. · Pubmed 29088323
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Program on Aging, Hebrew SeniorLife, Roslindale, Massachusetts, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: · Pubmed 28941963
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2016
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2012
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA. · Pubmed 22610119
2010
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA. · Pubmed 20233430
Probable:    Harvard University Boston   Contact    
2019
  • Department of Urology, Yale University, New Haven, Connecticut. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Comprehensive Cancer Center of Nevada, Las Vegas, Nevada. · Miriam Hospital, Providence, Rhode Island. · Virginia Oncology Associates, Hampton, Virginia. · Cancer Centers of the Carolinas, Greenville, South Carolina. · Western CT Health Network, Norwalk, Connecticut. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Virginia Cancer Center, Charlottesville, Virginia. · California Cancer Associates for Research & Excellence, Encinitas, California. · Cancer Centers of North Carolina, Raleigh, North Carolina. · Associates in Oncology and Hematology, Rockville, Maryland. · Progenics Pharmaceuticals, Inc., New York, New York. · Pubmed 30663074
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, QC, Canada. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Pathology Service, Addarii Institute of Oncology, S-Orsola-Malpighi Hospital, Bologna, IT, Italy. · Metabolon, Morrisville, NC, USA. · Decipher Biosciences, Vancouver, BC, Canada. · James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology, Mayo Clinic Rochester, Rochester, MN, USA. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Surgery Section, Durham Veteran Affairs Medical Center, Durham, NC, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Department of Pathology and Laboratory Medicine, Weil Cornell Medicine, New York Presbyterian-Weill Cornell Campus, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 31554818
2018
  • Department of Radiation Oncology, University of Michigan, Ann Arbor. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Medicine, Memorial Sloan Kettering Cancer Center New York, New York. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 29049492
2017
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Pubmed 28152172
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Division of Hematology/Oncology, University of California, Moores Cancer Center, San Diego, CA, USA. · Analysis Group, Inc., Boston, MA, USA. · Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28220804
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts. · Brigham and Women's Hospital, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27899381
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston · Robert W. Ross, Bluebird Bio, Cambridge, MA · Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX · Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI · Michael A. Carducci, Johns Hopkins University · Arif Hussain, Greenebaum Cancer Center, Baltimore, MD · Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI · and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland · Pubmed 26493203
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Channing Division of Network Medicine, 181 Longwood Avenue, Boston, MA 02115 USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, FL USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA USA. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA USA. · Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA 02139 USA. · Dana-Farber Cancer Institute, Boston, MA USA. · Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139 USA. · Pubmed 27980733
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics and Urology, University of California, San Francisco, California. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26847995
  • Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26778006
  • Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: · Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26767544
  • Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. Electronic address: · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. · Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Howard Hughes Medical Institute, Ann Arbor, MI, USA. Electronic address: · Pubmed 26724257
  • All authors: Dana-Farber Cancer Institute, Boston, MA. · All authors: Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26668348
  • Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Medical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Community-Based Research, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26502115
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26954420
2015
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 25577717
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25531313
  • Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. Electronic address: · Pubmed 25514466
  • Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · Department of Medicine, University Health Network, Toronto, Canada. · Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, and Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN, USA. · Academic Urology Unit, Department of Oncology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK. · Division of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 25097095
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Genitourinary Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology/Hematology Program, Greenebaum Cancer Center, Baltimore, Maryland. · Pubmed 25903013
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, Michigan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26575066
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Department of Epidemiology, University of Florida, Gainesville, Florida. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. · Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26469352
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26457646
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Pathology, Miami Baptist Hospital, Miami, Florida. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26393854
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26289068
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China. · Apple Tree Partners, New York, New York. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26181260
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · School of Health and Medical Sciences, Örebro University; and Department of Urology, Örebro University Hospital, Örebro, Sweden. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Pathology Unit, Addarii Institute, S Orsola-Malpighi Hospital, Bologna, Italy. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Trinity College, Dublin, Ireland. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Division of Cancer Studies, King's College London, London, United Kingdom. · Pubmed 26124442
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA (P.L.N., P.L.G., A.H.). · Department of Pathology, Brigham and Women's Hospital, Boston, MA (P.J.). · Endocrinology, Brigham and Women's Hospital, Boston, MA (S.B.). · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (J.P.Z., J.M., S.K., J.A.B.). · Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (P.W.K.). · Pubmed 25896892
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Epidemiology, Harvard School of Public Health, Boston, MA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. · Pubmed 25662905
  • Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA ; Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA ; Sunnybrook Health Sciences Centre, University of Toronto ON, Canada. · Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA ; Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA. · Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA. · Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA. · Pubmed 25625029
  • Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. · Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. · Pubmed 25623747
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington, Seattle, Washington. · University of Texas MD Anderson Cancer Center, Houston, Texas. · University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 25320358
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA. · Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25103271
2014
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School USA. · Department of Pathology, Beth-Israel Deaconess Medical Center, Harvard Medical School USA. · Department of Pathology, Massachusetts General Hospital, Harvard Medical School USA. · Pubmed 25606575
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · 1] Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada [2] Brigham and Women's Hospital, Boston, MA, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · 1] Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [2] Brigham and Women's Hospital, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Pubmed 25091040
  • Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan. · Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan2Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts4Center for Sur. · Pubmed 25179266
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 24925673
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115; and. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Pubmed 24778216
  • 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA. · Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA. · Pubmed 24752078
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Division of Urology, Brigham and Women's Hospital, 45 Francis Street, Boston, Boston, MA 02115, USA. · Division of Solid Tumor Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 24495697
  • Elahe A. Mostaghel, Rachel Hunter Merrill, and Roman Gulati, Fred Hutchinson Cancer Research Center · Elahe A. Mostaghel, Peter S. Nelson, Paul Lange, Daniel W. Lin, William Ellis, Robert Vessella, and Bruce Montgomery, University of Washington · Brett Marck, Alvin M. Matsumoto, and Lawrence D. True, Veterans Affairs Puget Sound Health Care System, Seattle, WA · Mary Ellen Taplin and Philip Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Steven Balk, Beth Israel Deaconess Medical Center, Boston, MA · and Daniel Tamae and Trevor Penning, University of Pennsylvania, Philadelphia, PA. · Pubmed 24323034
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Pubmed 23770851
2013
  • The Lank Center for Genitourinary Oncology and Solid Tumor Oncology at Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 23704236
  • Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA · Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA · Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML) · Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA · University of Dublin, Trinity College, Dublin, Ireland (RF, SF) · Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF) · Department of Medicine, McGill University, Montreal, QC, Canada (MP). · Pubmed 24292212
2012
  • Lank Center for Genitourinary Oncology, Division of Solid Tumor Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23040162
  • Departmentof Medical Oncology, Dana Farber Cancer, Institute, Harvard Medical School, 450 Brookline Ave., Boston, Massachusetts 02115. · Departmentof Medicine, Beth Israel Deaconess Medical, Center, Harvard Medical School, 330 Brookline Ave., Boston, Massachusetts 02115. · Pubmed 22127852
2010
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 20818862
2015
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 25135206
2014
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 24962506
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24668612
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 24604289
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24132762
2013
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 23798006
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Institute for Clinical and Economic Review, Institute for Technology Assessment, Boston, MA 02115, USA. · Pubmed 23778902
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23719969
  • Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23622249
  • Harvard Radiation Oncology Program, Boston, Massachusetts, USA. · Pubmed 23382116
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 22887127
  • The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 24114731
2012
  • Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 22928480
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22282219
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 21930687
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 23413607
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23239736
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA. · Pubmed 23138168
  • Division of Solid Tumor Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 23059047
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Pubmed 22736790
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22564379
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 22498212
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22112793
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21708431
2011
  • Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 22042952
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21958520
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21900597
  • Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 21700764
  • Dana-Farber Cancer Institute, Harvard Medical School, Dana 710B, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21606417
  • Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537050
  • Department of Nutrition, Harvard School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537045
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21367958
  • The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Pubmed 21307934
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21135144
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 20862742
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 20605366
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20477822
2010
  • Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21121759
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21119084
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Pubmed 21085629
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Pubmed 20978177
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20855462
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20615892
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 20424130
  • Laboratory of Nanomedicine & Biomaterials, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 20394530
  • Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20388772
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 201 total) written by Phillip W. Kantoff about Prostatic Neoplasms:

  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. 2020
  • Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics. 2020
  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. 2020
  • Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities. 2020
  • Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer. 2020
  • Treatment of Advanced Prostate Cancer. 2019
  • Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology. 2019
  • Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer. 2019
  • Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer. 2019
  • A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer. 2019
Show List of Full Article Records
Google Searches

Learn more about Phillip W. Kantoff using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Memorial Sloan-Kettering Cancer Center
NewYork-Presbyterian Hospitals
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Memorial Sloan-Kettering Cancer Center
2020
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 32385899
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 32317181
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
  • Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Jefferson College of Population Health, Philadelphia, PA, USA. Electronic address: · Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA. · Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Department of Pharmacy Practice, Jefferson College of Pharmacy, Philadelphia, PA, USA. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Jefferson Senior Adult Oncology Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Center for Prostate Disease Research (CPDR), Rockville, MD, USA. · Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA; Department of Urology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA. · Pubmed 31420248
  • Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Surgery, University of California, San Francisco, San Francisco, CA. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Pathology, Johns Hopkins Bayview Medical Center, Baltimore, MD. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA. · Pubmed 31318977
2019
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA; email: · Pubmed 30691365
  • Department of Urology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Section of Urology, Durham VA Medical Center, Durham, NC, USA. · Library for the Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, GU section, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA; Department of Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. Electronic address: · Pubmed 29673712
  • 1 National Institutes of Health, Bethesda, MD. · 2 Aarhus Universitetshospital, Åarhus, Denmark. · 3 Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · 4 St John of God Subiaco Hospital, Subiaco, Western Australia, Australia. · 5 University of Utah Huntsman Cancer Institute, Salt Lake City, UT. · 6 Royal Marsden Hospital, Sutton, United Kingdom. · 7 Monash Medical Centre, Bentleigh, Victoria, Australia. · 8 Herlev Hospital, Herlev, Denmark. · 9 University of Colorado Cancer Center, Aurora, CO. · 10 Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · 11 Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. · 12 Carolina Urologic Research Center, Myrtle Beach, SC. · 13 Bavarian Nordic, Morrisville, NC. · 14 Radboudumc, Nijmegen, the Netherlands. · 15 Centre Hospitalier Départemental, La Roche sur Yon, France. · 16 Aalborg Universitethospital, Aalborg, Denmark. · 17 North-Western State Medical University, Saint Petersburg, Russia. · 18 Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30817251
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, QC, Canada. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Pathology Service, Addarii Institute of Oncology, S-Orsola-Malpighi Hospital, Bologna, IT, Italy. · Metabolon, Morrisville, NC, USA. · Decipher Biosciences, Vancouver, BC, Canada. · James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology, Mayo Clinic Rochester, Rochester, MN, USA. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Surgery Section, Durham Veteran Affairs Medical Center, Durham, NC, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Department of Pathology and Laboratory Medicine, Weil Cornell Medicine, New York Presbyterian-Weill Cornell Campus, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 31554818
  • Division of Medical Oncology, Departments of Medicine and Urology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Division of Urology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Section of Hematology and Medical Oncology, Department of Medicine, Tulane Cancer Center and Tulane University School of Medicine, New Orleans, Louisiana. · Division of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Department of Surgery, Center for Prostate Disease Research at the Uniformed Services of Health Sciences, Bethesda, Maryland. · Associated Medical Professionals, Syracuse, New York. · Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, South Carolina. · New York Cancer and Blood Specialists, New York, New York. · Urology Associates PC, Nashville, Tennessee. · Chesapeake Urology, Towson, Maryland. · Department of Medical Oncology, GU Research Network, Omaha, Nebraska. · Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Advanced Urology, Atlanta, Georgia. · Prostate Cancer Research Institute, Marina del Rey, California. · Department of Biometrics, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Medical Affairs, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Pubmed 31483485
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 31225930
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL 33612. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115; · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; · Howard Hughes Medical Institute, Chevy Chase, MD 20815. · Pubmed 31085648
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Pathology, Weill Medical College of Cornell University, New York, NY 10021. · Department for Biomedical Research, University of Bern, 3008 Bern, Switzerland. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123 Trento, Italy. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109. · Department of Pathology, University of Michigan, Ann Arbor, MI 48109. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215. · Broad Institute, Cambridge, MA 02142. · Institute of Cancer Research, London SW7 3RP, United Kingdom. · The Royal Marsden National Health Service Foundation Trust, London SM2 5NG, United Kingdom. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Prostate Cancer Clinical Trials Consortium, New York, NY 10065. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021. · Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201. · Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109; · Department of Pathology, Weill Medical College of Cornell University, New York, NY 10021; · Department of Pathology, University of Michigan, Ann Arbor, MI 48109; · Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065. · Pubmed 31061129
  • HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA. Electronic address: · Department of Orthopaedic Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA; Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: · Department of Urology, Queen's University, Kingston, ON, Canada. Electronic address: · HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · HealthCore-NERI, 480 Pleasant Street, Watertown, MA 02472, USA; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: · Pubmed 30850323
  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Computer Science and Statistics, University of Rhode Island, South Kingstown, RI. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Mount Sinai School of Medicine, New York, NY. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 30664895
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Sapienza Università di Roma, Rome, Italy. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 30643173
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 30589920
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 30589919
  • HealthCore-NERI, Watertown, MA, USA. · Kingston General Hospital, Queen's University, Kingston, ON, Canada. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA. · Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA, USA. · Departments of Orthopaedic Surgery and Urology, Boston Children's Hospital, Boston, MA, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30216624
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Harvard T. H. Chan Harvard School of Public Health, Boston, Massachusetts. · Pubmed 30141208
2018
  • Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center · Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine · S. Bruce Malkowicz, University of Pennsylvania · Elias Obeid and Robert Uzzo, Fox Chase Cancer Center · Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia · Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA · Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center · Mitchell C. Benson, Columbia University, New York, NY · Gerald L. Andriole, Washington University School of Medicine, St Louis, MO · Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands · Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco · Christopher J. Kane, University of California San Diego, San Diego · Howard Sandler, Cedars-Sinai Medical Center, Los Angeles · Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA · Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore · Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD · William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine · Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL · Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT · David E. Crawford, University of Colorado, Aurora · Lawrence I. Karsh, The Urology Center of Colorado, Denver · Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO · Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA · Freddie C. Hamdy, University of Oxford, Oxford, England · R. Jeffrey Karnes, Mayo Clinic, Rochester, MN · Eric A. Klein, Cleveland Clinic, Cleveland · Robert Pilarski, The Ohio State University, Columbus, OH · Daniel W. Lin, University of Washington, Seattle, WA · Martin M. Miner, Brown University, Providence, RI · Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor · Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI · Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC · David F. Penson, Vanderbilt University Medical Center, Nashville, TN · Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT · Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston · Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX · Oliver Sartor, Tulane University Medical School, New Orleans, LA · Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC · and Richard Wender, American Cancer Society, Atlanta, GA. · Pubmed 29236593
  • Department of Urology, Osaka Medical College, Takatsuki, Osaka, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 29266472
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California. Electronic address: · University of Colorado Cancer Center, Aurora, Colorado. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Roswell Park Cancer Institute, Buffalo, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Janssen Scientific Affairs, LLC, Horsham, Pennsylvania. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29630978
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Oncology Division, Immunomic Therapeutics, Inc., Rockville, MD, USA. · Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. · Hematology Division, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medicine, Harvard Medical School, Boston, MA, USA. · Nanotechnology Engineering Program, University of Waterloo, Waterloo, Ontario, Canada. · David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. · Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · King Abdulaziz University, Jeddah, Saudi Arabia. · Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. · Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 31015614
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Medicine and Department of Pathology, David Geffen School of Medicine at University of California , Los Angeles, California. · Program on Aging, Hebrew Senior Life, Roslindale, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College , New York, New York. · Department of Radiation Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Pubmed 30325657
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, Trinity College Dublin, Dublin, Ireland. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California. · Department of Medicine, Clinical Epidemiology Unit, Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · National Cancer Institute, Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Bethesda, Maryland. · Pubmed 30108097
  • Department of Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. · Department of Epidemiology, Boston University School of Public Health, Boston, MA, 02118, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. · Pubmed 29915914
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · McMaster University, Hamilton, Ontario, Canada. · University of Colorado Denver, Denver, Colorado. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 29882250
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Urology and. · Translational Research Program, Osaka Medical College, Osaka, Japan. · Division of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Molecular Cytogenetics Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of General and Gastroenterological Surgery, Osaka Medical College, Osaka, Japan. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Pubmed 29863497
  • Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, Boston, Massachusetts. · Sapienza University of Rome, Rome, Italy. · Hospital Santa Izabel, Salvador, Bahia, Brazil. · University of Colorado Cancer Center, Aurora, Colorado. · Institut Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29707790
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Medicine, Division of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Englander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY, USA. · Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, NY, USA. · Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA. · Centre for Integrated Biology, University of Trento, Trento, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Pubmed 29610475
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 29338073
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Sapienza Università di Roma, Rome, Italy. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, AB, Canada. · St Vincent's Hospital, Sydney, Australia. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 29331381
  • Harvard Radiation Oncology Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Computer Science and Statistics, University of Rhode Island, Kingston, Rhode Island. · Department of Pathology, Baptist Hospital and Miami Cancer Institute, Miami, Florida. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, University of California at San Francisco, San Francisco, California. · Pubmed 29266181
  • Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA, USA. · Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Surgery, Division of Urology, Dana Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Department of Urology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 29263420
  • Department of Medicine, Duke Cancer Institute, Durham, New York, USA. · Department of Oncology, Johns Hopkins University, Baltimore, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, Weill Cornell Medical College, New York, USA. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA. · Carolina Urologic Research Center, Myrtle Beach, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Weill Cornell Medical College, New York, USA. · Department of Medicine, MD Anderson Cancer Center, Houston, USA. · School of Medicine, University of Virginia, Charlottesville, USA. · Division of Hematology/Oncology, Wayne State University, Detroit, USA. · Division of Hematology/Oncology, University of Wisconsin, Madison, USA. · Department of Medicine, Rutgers Cancer Institute of New Jersey, Newark, USA. · Massachusetts General Hospital, Cancer Center, Boston, USA. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Division of Human Biology, University of Washington, Seattle, USA. · Fred Hutchinson Cancer Center, Seattle, USA. · Department of Urology, The Christie Clinic, National Health Service, Manchester, UK. · Department of Urology, UC Davis, Sacramento, USA. · Department of Oncology, University Hospital Aschen, Cologne, Germany. · Department of Urology, University Hospital St. Etienne, Saint-Etienne, France. · Department of Urologic Sciences, Vancouver Prostate Centre, Vancouver, Canada. · Pubmed 29088323
  • Department of Radiation Oncology, University of Michigan, Ann Arbor. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Medicine, Memorial Sloan Kettering Cancer Center New York, New York. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 29049492
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Program on Aging, Hebrew SeniorLife, Roslindale, Massachusetts, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: · Pubmed 28941963
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2017
  • Lorelei A. Mucci, Harvard TH Chan School of Public Health, Boston, MA · and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28817369
  • Fred Hutchinson Cancer Research Center, Seattle, Washington. · Palo Alto Medical Foundation, Palo Alto, California. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · Lerner Research Institute, Glickman Urological and Kidney Institute, and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington. · University of Washington, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28389510
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY · James L. Gulley, National Cancer Institute, Bethesda, MD · and Cesar Pico-Navarro, Bavarian Nordic, Redwood City, CA. · Pubmed 27646950
  • Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Pubmed 28886115
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA · Marc Buyse, International Drug Development Institute · Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve · Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium · Susan Halabi, Duke University Medical Center, Durham, NC · Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY · Oliver Sartor, Tulane Medical School, New Orleans, LA · Howard Soule, Prostate Cancer Foundation, Santa Monica · Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA · Noel W. Clarke, The Christie NHS Foundation Trust, Manchester · Matthew R. Sydes, University College London, London, United Kingdom · James J. Dignam, University of Chicago, Chicago, IL · Karim Fizazi, Institut Gustave-Roussy, Villejuif, France · Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada · and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, Ohio State University, Columbus, Ohio. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Pubmed 28700821
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts. · Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Physics of Complex Systems Eotvos Lorand University, Budapest, Hungary. · Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. · Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Institute, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, New York. · Pubmed 28608931
  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Division of Hematology/Oncology, University of California, Moores Cancer Center, San Diego, CA, USA. · Analysis Group, Inc., Boston, MA, USA. · Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28220804
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28117382
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts2Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Baptist Hospital, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Institute, New York, New York. · Pubmed 28097317
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27824043
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston · Robert W. Ross, Bluebird Bio, Cambridge, MA · Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX · Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI · Michael A. Carducci, Johns Hopkins University · Arif Hussain, Greenebaum Cancer Center, Baltimore, MD · Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI · and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • University of Wisconsin Carbone Cancer Center, 7007 WIMR, 1111 Highland Avenue, Madison, WI 53705 USA. · Weill Medical College of Cornell University, Laboratory of Urological Oncology E-300, 525 East 68th Street, New York, NY 10021 USA. · Oregon Health and Science University Knight Cancer Institute, 3181 SW Sam Jackson Park Road, Portland, OR 97239 USA. · Johns Hopkins University, 1650 Orleans Street Room 410, Baltimore, MD 21287 USA. · University of California, San Francisco, 513 Parnassus Ave, Room HSF 301, Box 1270, San Francisco, CA 94143 USA. · Carolina Urologic Research Center, 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572 USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 USA. · National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892 USA. · Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1079, New York, NY 10029 USA. · University of Illinois, 840 S Wood Street, Suite 820, Chicago, IL 60612 USA. · Yale Cancer Center, PO Box 208032, New Haven, CT 06520 USA. · Alliance for Prostate Cancer Prevention, 17660 Tamiami Trail, Suite 106, Fort Myers, FL 33908 USA. · Tulane University School of Medicine, 1430 Tulane Ave, SL-42, New Orleans, LA 70112 USA. · Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903 USA. · Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328 USA. · Genitourinary Malignancies Branch, 10 Center Drive, 13N240, Bethesda, MD 20892 USA. · Pubmed 28031820
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute · Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA · Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT · Andrew Renshaw, Miami Baptist Hospital, Miami, FL · and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Department of Urology, Weill Cornell Medical Center, 1300 York Avenue, New York, NY, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, 600 Third Avenue, New York, NY, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Pubmed 27439668
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
2012
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 22802323
NewYork-Presbyterian Hospitals
2020
  • Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: · University College London Cancer Institute, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Urology, Skåne University Hospital, Malmö, Sweden. · Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. · Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK. · BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · The Christie and Salford Royal Hospitals, Manchester, UK. · Monash University and Eastern Health, Victoria, Australia. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK. · Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of California Davis School of Medicine, Sacramento, CA, USA. · Policlinico S.Orsola, Università di Bologna, Italy. · University of California San Francisco, San Francisco, CA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria. · Department of Oncology, Akershus University Hospital, Lørenskog, Norway. · University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. · The Institute of Cancer Research, London, UK. · Division of Medical Oncology, National Cancer Centre, Singapore. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon. · Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece. · Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. · UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · University Hospital Nord, St Etienne, France. · National Institute of Oncology, University hospital, Rabat, Morocco. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Tata Memorial Centre, Mumbai, India. · Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK. · Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK. · Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong. · Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. · University of California Los Angeles, Los Angeles, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Bern Center for Precision Medicine, Bern, Switzerland; Department for Biomedical Research, University of Bern, Bern, Switzerland. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. · Centre Hospitalier de Université de Montréal, Montreal, Canada. · Instituto Alexander Fleming, Buenos Aires, Argentina. · Tulane Cancer Center, New Orleans, LA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Division of Hematology and Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. · Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Toho University Sakura Medical Center, Chiba, Japan. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Urology, M.A. Aydınlar Acıbadem University, Altunizade Hospital, Istanbul, Turkey. · Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, University Hospital La Princesa, Health Research Institute, Madrid, Spain. · University of Bern, Bern, Switzerland; Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. · Pubmed 32001144
2019
  • Division of Medical Oncology, Departments of Medicine and Urology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Division of Urology, Duke University Medical Center, Duke Cancer Institute, Duke University, Durham, North Carolina. · Section of Hematology and Medical Oncology, Department of Medicine, Tulane Cancer Center and Tulane University School of Medicine, New Orleans, Louisiana. · Division of Hematology/Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Department of Surgery, Center for Prostate Disease Research at the Uniformed Services of Health Sciences, Bethesda, Maryland. · Associated Medical Professionals, Syracuse, New York. · Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, South Carolina. · New York Cancer and Blood Specialists, New York, New York. · Urology Associates PC, Nashville, Tennessee. · Chesapeake Urology, Towson, Maryland. · Department of Medical Oncology, GU Research Network, Omaha, Nebraska. · Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. · Advanced Urology, Atlanta, Georgia. · Prostate Cancer Research Institute, Marina del Rey, California. · Department of Biometrics, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Medical Affairs, Dendreon Pharmaceuticals LLC, Seattle, Washington. · Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Pubmed 31483485
  • HealthCore-NERI, Watertown, MA, USA. · Kingston General Hospital, Queen's University, Kingston, ON, Canada. · Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA. · Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA, USA. · Departments of Orthopaedic Surgery and Urology, Boston Children's Hospital, Boston, MA, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 30216624
2018
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Medicine and Department of Pathology, David Geffen School of Medicine at University of California , Los Angeles, California. · Program on Aging, Hebrew Senior Life, Roslindale, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College , New York, New York. · Department of Radiation Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts. · Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School , Boston, Massachusetts. · Pubmed 30325657
  • Department of Medicine, Duke Cancer Institute, Durham, New York, USA. · Department of Oncology, Johns Hopkins University, Baltimore, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, Weill Cornell Medical College, New York, USA. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA. · Carolina Urologic Research Center, Myrtle Beach, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Weill Cornell Medical College, New York, USA. · Department of Medicine, MD Anderson Cancer Center, Houston, USA. · School of Medicine, University of Virginia, Charlottesville, USA. · Division of Hematology/Oncology, Wayne State University, Detroit, USA. · Division of Hematology/Oncology, University of Wisconsin, Madison, USA. · Department of Medicine, Rutgers Cancer Institute of New Jersey, Newark, USA. · Massachusetts General Hospital, Cancer Center, Boston, USA. · Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. · Division of Human Biology, University of Washington, Seattle, USA. · Fred Hutchinson Cancer Center, Seattle, USA. · Department of Urology, The Christie Clinic, National Health Service, Manchester, UK. · Department of Urology, UC Davis, Sacramento, USA. · Department of Oncology, University Hospital Aschen, Cologne, Germany. · Department of Urology, University Hospital St. Etienne, Saint-Etienne, France. · Department of Urologic Sciences, Vancouver Prostate Centre, Vancouver, Canada. · Pubmed 29088323
  • Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Program on Aging, Hebrew SeniorLife, Roslindale, Massachusetts, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: · Pubmed 28941963
  • Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. Electronic address: · Department of Medical Oncology, The Institute of Cancer Research/Royal Marsden, London, UK. · Oregon Health & Science University Knight Cancer Institute, OR, USA. · Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France. · Department of Radiation Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, USA. · Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY, USA. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. · Department of Urology, The Christie and Salford Royal Hospitals, Manchester, UK. · Department of Medical Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Department of Urology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. · Department of Medical Oncology, Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA. · Department of Clinical Oncology and Genetics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, University of Texas MD Anderson Cancer Center, TX, USA. · Department of Urology, University of California, Davis School of Medicine, CA, USA. · Department of Nuclear Medicine, Policlinico S. Orsola, Università di Bologna, Italy. · Department of Radiation Oncology, University of California, San Francisco, CA, USA. · Department of Medical Oncology, Gustave Roussy, University of Paris Sud, Paris, France. · Department of Surgery, Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University. · Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Department of Clinical trials and Statistics, Duke University, Durham, NC, USA. · Department of Urology, University Hospital Köln, Köln, Germany. · Department of Medicine, Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, WA, USA. · Department of Clinical Oncology, Clinical Oncology Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Clinical Oncology, Tampere University Hospital, Faculty of Medicine and Life Sciences, University of Tampere, Finland. · Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA. · Department of Medical Oncology Hospital Israelita Albert Einstein and Department of Medical Oncology Beneficência Portuguesa de São Paulo. · Department of Medical Oncology and Epidemiology, Vanderbilt University Medical Center, Division of Hematology/Oncology, Nashville, TN, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Urology, University Hospital Nord St. Etienne, St. Etienne, France. · Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India. · Department of Medical Oncology, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA. · Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. · Department of Radiology, Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK. · Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK. · Department of Pathology, University of Washington, WA, USA. · Department of Pathology, University of Bern and the Inselspital, Bern (CH). · Department of Medical Oncology, Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of, California, San Francisco, CA, USA. · Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Department of Medical Oncology, Tulane Cancer Center, New Orleans, LA, USA. · Department of Medical Oncology, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Centre, New York, NY, USA. · Department of Medical Oncology, Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Department of Medical Oncology, Massachusetts General Hospital Cancer Centre, Boston, MA, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. · Department of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Department of Urology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Oncology and Haemato-oncology, Università degli Studi di Milano. Radiation Oncology 1, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Radiation Oncology, Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikum Ulm, Albert-Einstein-Allee, Ulm, Germany. · Department of Medical Oncology, Cantonal Hospital St. Gallen and University of Berne, Switzerland. · Pubmed 28655541
2016
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2012
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA. · Pubmed 22610119
2010
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA. · Pubmed 20233430
Harvard University Boston
2019
  • Department of Urology, Yale University, New Haven, Connecticut. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Comprehensive Cancer Center of Nevada, Las Vegas, Nevada. · Miriam Hospital, Providence, Rhode Island. · Virginia Oncology Associates, Hampton, Virginia. · Cancer Centers of the Carolinas, Greenville, South Carolina. · Western CT Health Network, Norwalk, Connecticut. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Virginia Cancer Center, Charlottesville, Virginia. · California Cancer Associates for Research & Excellence, Encinitas, California. · Cancer Centers of North Carolina, Raleigh, North Carolina. · Associates in Oncology and Hematology, Rockville, Maryland. · Progenics Pharmaceuticals, Inc., New York, New York. · Pubmed 30663074
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, QC, Canada. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Pathology Service, Addarii Institute of Oncology, S-Orsola-Malpighi Hospital, Bologna, IT, Italy. · Metabolon, Morrisville, NC, USA. · Decipher Biosciences, Vancouver, BC, Canada. · James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. · Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. · Department of Urology, Mayo Clinic Rochester, Rochester, MN, USA. · Department of Surgery, Division of Urology, Center for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Surgery Section, Durham Veteran Affairs Medical Center, Durham, NC, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · The Broad Institute of MIT and Harvard University, Cambridge, MA, USA. · Department of Pathology and Laboratory Medicine, Weil Cornell Medicine, New York Presbyterian-Weill Cornell Campus, New York, NY, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 31554818
2018
  • Department of Radiation Oncology, University of Michigan, Ann Arbor. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Medicine, Memorial Sloan Kettering Cancer Center New York, New York. · Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 29049492
2017
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Pubmed 28152172
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Division of Hematology/Oncology, University of California, Moores Cancer Center, San Diego, CA, USA. · Analysis Group, Inc., Boston, MA, USA. · Bayer Healthcare Pharmaceuticals, Wayne, NJ, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28220804
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts. · Brigham and Women's Hospital, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27899381
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston · Robert W. Ross, Bluebird Bio, Cambridge, MA · Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX · Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI · Michael A. Carducci, Johns Hopkins University · Arif Hussain, Greenebaum Cancer Center, Baltimore, MD · Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ · Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI · and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland · Pubmed 26493203
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Channing Division of Network Medicine, 181 Longwood Avenue, Boston, MA 02115 USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, FL USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA USA. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA USA. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA USA. · Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, MA 02139 USA. · Dana-Farber Cancer Institute, Boston, MA USA. · Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139 USA. · Pubmed 27980733
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics and Urology, University of California, San Francisco, California. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26847995
  • Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26778006
  • Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: · Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26767544
  • Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. Electronic address: · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. · Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Howard Hughes Medical Institute, Ann Arbor, MI, USA. Electronic address: · Pubmed 26724257
  • All authors: Dana-Farber Cancer Institute, Boston, MA. · All authors: Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26668348
  • Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Medical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Community-Based Research, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26502115
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26954420
2015
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 25577717
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25531313
  • Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. Electronic address: · Pubmed 25514466
  • Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · Department of Medicine, University Health Network, Toronto, Canada. · Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, and Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN, USA. · Academic Urology Unit, Department of Oncology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK. · Division of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 25097095
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Genitourinary Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology/Hematology Program, Greenebaum Cancer Center, Baltimore, Maryland. · Pubmed 25903013
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles · Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA · Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom · Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia · Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Celestia S. Higano, University of Washington, Seattle, WA · Jinhui Li, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, Michigan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26575066
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Department of Epidemiology, University of Florida, Gainesville, Florida. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. · Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26469352
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26457646
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Pathology, Miami Baptist Hospital, Miami, Florida. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26393854
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26289068
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China. · Apple Tree Partners, New York, New York. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26181260
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · School of Health and Medical Sciences, Örebro University; and Department of Urology, Örebro University Hospital, Örebro, Sweden. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Pathology Unit, Addarii Institute, S Orsola-Malpighi Hospital, Bologna, Italy. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Trinity College, Dublin, Ireland. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Division of Cancer Studies, King's College London, London, United Kingdom. · Pubmed 26124442
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA (P.L.N., P.L.G., A.H.). · Department of Pathology, Brigham and Women's Hospital, Boston, MA (P.J.). · Endocrinology, Brigham and Women's Hospital, Boston, MA (S.B.). · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (J.P.Z., J.M., S.K., J.A.B.). · Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (P.W.K.). · Pubmed 25896892
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Epidemiology, Harvard School of Public Health, Boston, MA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. · Pubmed 25662905
  • Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA ; Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA ; Sunnybrook Health Sciences Centre, University of Toronto ON, Canada. · Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA ; Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA. · Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA. · Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA. · Pubmed 25625029
  • Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. · Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. · Pubmed 25623747
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington, Seattle, Washington. · University of Texas MD Anderson Cancer Center, Houston, Texas. · University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 25320358
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA. · Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25103271
2014
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School USA. · Department of Pathology, Beth-Israel Deaconess Medical Center, Harvard Medical School USA. · Department of Pathology, Massachusetts General Hospital, Harvard Medical School USA. · Pubmed 25606575
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center · Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA · Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington · Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System · Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA · Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX · Martin G. Sanda, Emory University School of Medicine, Atlanta, GA · Massimo Loda, King's College London, London, United Kingdom · Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA · and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · 1] Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada [2] Brigham and Women's Hospital, Boston, MA, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · 1] Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [2] Brigham and Women's Hospital, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Pubmed 25091040
  • Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan. · Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan2Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts4Center for Sur. · Pubmed 25179266
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 24925673
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115; and. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Pubmed 24778216
  • 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA. · Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA. · Pubmed 24752078
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Division of Urology, Brigham and Women's Hospital, 45 Francis Street, Boston, Boston, MA 02115, USA. · Division of Solid Tumor Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 24495697
  • Elahe A. Mostaghel, Rachel Hunter Merrill, and Roman Gulati, Fred Hutchinson Cancer Research Center · Elahe A. Mostaghel, Peter S. Nelson, Paul Lange, Daniel W. Lin, William Ellis, Robert Vessella, and Bruce Montgomery, University of Washington · Brett Marck, Alvin M. Matsumoto, and Lawrence D. True, Veterans Affairs Puget Sound Health Care System, Seattle, WA · Mary Ellen Taplin and Philip Kantoff, Dana-Farber Cancer Institute, Harvard Medical School · Steven Balk, Beth Israel Deaconess Medical Center, Boston, MA · and Daniel Tamae and Trevor Penning, University of Pennsylvania, Philadelphia, PA. · Pubmed 24323034
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Pubmed 23770851
2013
  • The Lank Center for Genitourinary Oncology and Solid Tumor Oncology at Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 23704236
  • Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA · Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA · Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML) · Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA · University of Dublin, Trinity College, Dublin, Ireland (RF, SF) · Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF) · Department of Medicine, McGill University, Montreal, QC, Canada (MP). · Pubmed 24292212
2012
  • Lank Center for Genitourinary Oncology, Division of Solid Tumor Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23040162
  • Departmentof Medical Oncology, Dana Farber Cancer, Institute, Harvard Medical School, 450 Brookline Ave., Boston, Massachusetts 02115. · Departmentof Medicine, Beth Israel Deaconess Medical, Center, Harvard Medical School, 330 Brookline Ave., Boston, Massachusetts 02115. · Pubmed 22127852
2010
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 20818862
2015
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 25135206
2014
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 24962506
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24668612
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 24604289
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24132762
2013
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 23798006
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Institute for Clinical and Economic Review, Institute for Technology Assessment, Boston, MA 02115, USA. · Pubmed 23778902
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23719969
  • Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23622249
  • Harvard Radiation Oncology Program, Boston, Massachusetts, USA. · Pubmed 23382116
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 22887127
  • The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 24114731
2012
  • Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 22928480
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22282219
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 21930687
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 23413607
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23239736
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA. · Pubmed 23138168
  • Division of Solid Tumor Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 23059047
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Pubmed 22736790
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22564379
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 22498212
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22112793
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21708431
2011
  • Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 22042952
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21958520
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21900597
  • Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 21700764
  • Dana-Farber Cancer Institute, Harvard Medical School, Dana 710B, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21606417
  • Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537050
  • Department of Nutrition, Harvard School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537045
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21367958
  • The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Pubmed 21307934
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21135144
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 20862742
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 20605366
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20477822
2010
  • Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21121759
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21119084
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Pubmed 21085629
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Pubmed 20978177
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20855462
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20615892
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 20424130
  • Laboratory of Nanomedicine & Biomaterials, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 20394530
  • Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20388772
University of Washington
2019
  • Department of Medicine, University of California at San Diego, San Diego, California. · Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, University of Washington at Seattle, Seattle, Washington. · Department of Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 30427533
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
Miscellaneous institutions in New York City
2016
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
Unspecified
2015
  • Department of Medical Oncology, and. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington School of Medicine, Seattle, Washington. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Department of Medical Oncology, and · Pubmed 25808865
2014
  • Center for Molecular Oncologic Pathology; Departments of Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland · Channing Division of Network Medicine, Department of Medicine; Department of Epidemiology, Harvard School of Public Health; and. · Center for Molecular Oncologic Pathology; Departments of. · Center for Molecular Oncologic Pathology; Departments of Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Radiation Oncology, Dana Farber Cancer Institute; · Medical Oncology and. · Division of Preventive Medicine, Brigham and Women's Hospital; · Center for Molecular Oncologic Pathology; Departments of Medical Oncology and. · Pubmed 24687926
Miscellaneous institutions in Mountain View
2010
  • Medical Director, BN ImmunoTherapeutics, 2425 Garcia Ave, Mountain View, CA 94043, USA. · Pubmed 20100959
25 Other Locations Show
Yearly article counts 517201721281918231815
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.